Neuroinflammation correlates with tau in patients with MCI

PET imaging reveals co-localization of neuroinflammation and tau in patients with amnestic mild cognitive impairment (MCI), a new study has demonstrated.

Neuroinflammation is a potential diagnostic biomarker of Alzheimer’s disease (AD), but the role of inflammation across various stages of AD has not been defined, said the researchers in Houston, Texas, USA. They assessed the degree of neuroinflammation, and its correlation with other biomarkers (amyloid and tau) in patients with amnestic MCI.